Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 5 Similar Profiles
Lymphoma Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Phosphatidylinositol 3-Kinase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL

Byrd, J. C., Smith, S., Wagner-Johnston, N., Sharman, J., Chen, A. I., Advani, R., Augustson, B., Marlton, P., Commerford, S. R., Okrah, K., Liu, L., Murray, E., Penuel, E., Ward, A. F. & Flinn, I. W. Jan 1 2018 In : Oncotarget. 9, 16, p. 13023-13035 13 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
Human Influenza
Mutation

Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial

Brown, J. R. , Hamadani, M. , Hayslip, J. , Janssens, A. , Wagner-Johnston, N. , Ottmann, O. , Arnason, J. , Tilly, H. , Millenson, M. , Offner, F. , Gabrail, N. Y. , Ganguly, S. , Ailawadh, S. , Kasar, S. , Kater, A. P. , Doorduijn, J. K. , Gao, L. , Lager, J. J. , Wu, B. , Egile, C. & 1 others Kersten, M. J. Jan 1 2018 (Accepted/In press) In : The Lancet Haematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
Mantle-Cell Lymphoma
Follicular Lymphoma
Safety

A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

Garzon, R., Savona, M., Baz, R., Andreeff, M., Gabrail, N., Gutierrez, M., Savoie, L., Mau-Sorensen, P. M., Wagner-Johnston, N., Yee, K., Unger, T. J., Saint-Martin, J. R., Carlson, R., Rashal, T., Kashyap, T., Klebanov, B., Shacham, S., Kauffman, M. & Stone, R. Jun 15 2017 In : Blood. 129, 24, p. 3165-3174 10 p.

Research output: Contribution to journalArticle

Clinical Trials, Phase I
Acute Myeloid Leukemia
Toxicity
Refractory materials
Hazards

A phase 2/3 multicenter, randomized, open-label study to compare the efficacy and safety of lenalidomide versus investigator's choice in patients with relapsed or refractory diffuse large B-cell lymphoma

Czuczman, M. S. , Trněný, M. , Davies, A. , Rule, S. , Linton, K. M. , Wagner-Johnston, N. , Gascoyne, R. D. , Slack, G. W. , Brousset, P. , Eberhard, D. A. , Hernandez-Ilizaliturri, F. J. , Salles, G. , Witzig, T. E. , Zinzani, P. L. , Wright, G. W. , Staudt, L. M. , Yang, Y. , Williams, P. M. , Lih, C. J. , Russo, J. & 5 others Thakurta, A., Hagner, P., Fustier, P., Song, D. & Lewis, I. D. Aug 1 2017 In : Clinical Cancer Research. 23, 15, p. 4127-4137 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Research Personnel
Safety
Germinal Center

A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma

Maly, J. J., Christian, B. A., Zhu, X., Wei, L., Sexton, J. L., Jaglowski, S. M., Devine, S. M., Fehniger, T. A., Wagner-Johnston, N. D., Phelps, M. A., Bartlett, N. L. & Blum, K. A. Jun 1 2017 In : Clinical Lymphoma, Myeloma and Leukemia. 17, 6, p. 347-353 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Lymphocytes
Safety
panobinostat
lenalidomide